The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma-Reference-Cited by-同舟云学术

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma

Published:2017-04-11 Issue:1 Volume:16 Page:55-68
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comp Oncol

Author:

Keller Alexandra¹²^ORCID,Wingelhofer Bettina³,Peter Barbara¹²,Bauer Karin¹,Berger Daniela¹,Gamperl Susanne¹,Reifinger Martin⁴,Cerny-Reiterer Sabine¹²,Moriggl Richard³,Willmann Michael⁵,Valent Peter¹²,Hadzijusufovic Emir¹²⁵

Affiliation:

1. Department of Internal Medicine I, Division of Hematology and Hemostaseology; Medical University of Vienna; Vienna Austria

2. Ludwig Boltzmann Cluster Oncology; Medical University of Vienna; Vienna Austria

3. Ludwig Boltzmann Institute for Cancer Research, Institute of Animal Breeding and Genetics; University of Veterinary Medicine Vienna, Medical University of Vienna; Vienna Austria

4. Institute of Pathology and Forensic Veterinary Medicine, Department of Pathobiology; University of Veterinary Medicine Vienna; Vienna Austria

5. Department of Companion Animals and Horses, Small Animal Clinic, Internal Medicine; University of Veterinary Medicine Vienna; Vienna Austria

Funder

Oesterreichische Nationalbank

Austrian Science Fund

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vco.12311/fullpdf

Reference53 articles.

1. Skin tumors in domestic animals. Data from 21 US and Canadian colleges of veterinary medicine;Priester;J Natl Cancer Inst,1973

2. Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital;Cohen;Cancer Res,1974

3. Survery of animal neoplasms in Alameda and Contra Costa counties, California II. Cancer morbidity in dogs and cats from Almeda County;Dorn;J Natl Cancer Inst,1968

4. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment;Welle;Vet Dermatol,2008

5. Canine cutaneous mast cell tumors: morphologic grading and survival time in 83 dogs;Patnaik;Vet Pathol,1984

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells;Frontiers in Immunology;2024-08-12

2. Molecular Characteristics of JAK2 and Its Effect on the Milk Fat and Casein Synthesis of Ovine Mammary Epithelial Cells;International Journal of Molecular Sciences;2024-04-04

3. A randomised, double‐blinded trial to assess the effect of oclacitinib and prednisolone on intradermal allergen and prick tests in dogs with atopic dermatitis;Veterinary Dermatology;2023-09-28

4. Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma;Biomedicines;2023-08-23

5. A facile and high-sensitive bio-sensing of the V617F mutation in JAK2 gene by GSH-CdTe-QDs FRET-based sensor;Heliyon;2022-12